183 related articles for article (PubMed ID: 30669641)
1. Crohn's Disease Patients in Remission Display an Enhanced Intestinal IgM⁺ B Cell Count in Concert with a Strong Activation of the Intestinal Complement System.
Preisker S; Brethack AK; Bokemeyer A; Bettenworth D; Sina C; Derer S
Cells; 2019 Jan; 8(1):. PubMed ID: 30669641
[TBL] [Abstract][Full Text] [Related]
2. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
[TBL] [Abstract][Full Text] [Related]
4. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
MacDermott RP; Schreiber S; Nash GS; Koopman WJ
Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
[TBL] [Abstract][Full Text] [Related]
5. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
[TBL] [Abstract][Full Text] [Related]
6. B lymphocyte intestinal homing in inflammatory bowel disease.
Defendenti C; Sarzi-Puttini P; Grosso S; Croce A; Senesi O; Saibeni S; Bollani S; Almasio PL; Bruno S; Atzeni F
BMC Immunol; 2011 Dec; 12():71. PubMed ID: 22208453
[TBL] [Abstract][Full Text] [Related]
7. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease.
Lin R; Chen H; Shu W; Sun M; Fang L; Shi Y; Pang Z; Wu W; Liu Z
J Transl Med; 2018 Dec; 16(1):359. PubMed ID: 30558634
[TBL] [Abstract][Full Text] [Related]
10. Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.
Baklien K; Brandtzaeg P
Clin Exp Immunol; 1975 Nov; 22(2):197-209. PubMed ID: 1082398
[TBL] [Abstract][Full Text] [Related]
11. Imbalance of Controlled Death in Peripheral Blood Lymphocytes in Crohn's Disease and Ulcerative Colitis.
Dudzińska E; Szymona K; Gil-Kulik P; Chomik P; Świstowska M; Gryzińska M; Kocki J
Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31159239
[No Abstract] [Full Text] [Related]
12. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
15. The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function.
Sina C; Kemper C; Derer S
Semin Immunol; 2018 Jun; 37():66-73. PubMed ID: 29486961
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
17. In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.
Danis VA; Harries AD; Heatley RV
Clin Exp Immunol; 1984 Apr; 56(1):159-66. PubMed ID: 6713728
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
[TBL] [Abstract][Full Text] [Related]
19. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
[TBL] [Abstract][Full Text] [Related]
20. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
